Longevity Research

Bi
Split-image illustration of frail elderly male lab mice before and after drug treatment extending lifespan by 73%, with UC Berkeley lab setting.
Hoton da AI ya samar

Drug combo extends remaining lifespan of frail elderly male mice by about 70%

An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya

A combination of oxytocin and an Alk5 inhibitor significantly extended remaining lifespan and improved health in very old, frail male mice, according to research from the University of California, Berkeley. The treatment increased their remaining life by about 73% but did not lengthen lifespan in females, underscoring key sex differences in aging biology and in responses to longevity therapies.

Wannan shafin yana amfani da cookies

Muna amfani da cookies don nazari don inganta shafin mu. Karanta manufar sirri mu don ƙarin bayani.
Ƙi